Dublin-based Neuromod has raised €10.5m and plans to further fuel Lenire's commercialisation in Europe and reach US veterans.

Irish medtech company Neuromod has raised €10m in equity financing to expand the production of Lenire – a device that helps ...

Neuromod Devices Ltd. raised €10 million (US$10.9 million) in financing to expand the reach of Lenire, which treats tinnitus.

Neuromod Devices has secured €10m ($10.8m) in equity financing to broaden the reach of Lenire, its treatment device.

Dublin-based company has developed an FDA-approved device called Lenire that is for use with patients suffering from tinnitus ...

Neuromod Devices announced today that it closed an equity financing round worth proceeds of about $10.9 million (€10 million) ...

Irish medtech group Neuromod Devices has raised €10 million equity financing to expand the availability of its tinnitus ...

Neuromod has closed a €10m round of equity financing as it looks to expand the availability of its tinnitus treatment device ...

Neuromod Devices Ltd. (Neuromod), an Irish medical device company specialising in tinnitus, has successfully closed a ?10 million equity financing to expand the availability of its tinnitus treatment ...

Neuromod Devices Ltd. (Neuromod), an Irish medical device company specialising in tinnitus, has successfully closed a €10 ...